Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions
出版年份 2013 全文链接
标题
Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions
作者
关键词
-
出版物
Annals of the New York Academy of Sciences
Volume 1291, Issue 1, Pages 42-55
出版商
Wiley
发表日期
2013-05-24
DOI
10.1111/nyas.12136
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rivaroxaban for Thromboprophylaxis in Acutely Ill Medical Patients
- (2013) Alexander T. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Executive Summary
- (2012) Gordon H. Guyatt et al. CHEST
- Heart Disease and Stroke Statistics—2013 Update
- (2012) Alan S. Go et al. CIRCULATION
- Rivaroxaban vs. Warfarin in Japanese Patients With Atrial Fibrillation
- (2012) Masatsugu Hori et al. CIRCULATION JOURNAL
- Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents
- (2012) Subrata Kar et al. CORONARY ARTERY DISEASE
- Effect of dosing frequency on chronic cardiovascular disease medication adherence
- (2012) Craig I. Coleman et al. CURRENT MEDICAL RESEARCH AND OPINION
- ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
- (2012) et al. EUROPEAN HEART JOURNAL
- Danger Ahead: Watch Out for Indirect Comparisons!⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
- (2012) Christopher P. Cannon et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- The discovery and development of rivaroxaban
- (2011) Frank Misselwitz et al. Annals of the New York Academy of Sciences
- Rivaroxaban
- (2011) Wolfgang Mueck et al. CLINICAL PHARMACOKINETICS
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
- (2011) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Venous and arterial thrombosis – pathogenesis and the rationale for anticoagulation
- (2011) Charles Esmon et al. THROMBOSIS AND HAEMOSTASIS
- Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study
- (2010) AMERICAN HEART JOURNAL
- Clinical Classification and Plaque Morphology Determined by Optical Coherence Tomography in Unstable Angina Pectoris
- (2010) Masato Mizukoshi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPACE
- The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
- (2010) Elisabeth Perzborn et al. NATURE REVIEWS DRUG DISCOVERY
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty
- (2010) Michael Rud Lassen et al. THROMBOSIS AND HAEMOSTASIS
- Metabolism and Excretion of Rivaroxaban, an Oral, Direct Factor Xa Inhibitor, in Rats, Dogs, and Humans
- (2009) C. Weinz et al. DRUG METABOLISM AND DISPOSITION
- Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement
- (2009) B. I. Eriksson et al. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
- Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
- (2009) Timothy Watson et al. LANCET
- Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial
- (2009) JL Mega et al. LANCET
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
- (2009) Alexander GG Turpie et al. LANCET
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study
- (2008) H. R. Buller et al. BLOOD
- Antithrombotic Therapy in Atrial Fibrillation
- (2008) Daniel E. Singer et al. CHEST
- Antithrombotic Therapy for Venous Thromboembolic Disease
- (2008) Clive Kearon et al. CHEST
- Pharmacology and Management of the Vitamin K Antagonists
- (2008) Jack Ansell et al. CHEST
- Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects
- (2008) Dagmar Kubitza et al. CURRENT MEDICAL RESEARCH AND OPINION
- Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial
- (2008) Ajay K Kakkar et al. LANCET
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
- (2008) Bengt I. Eriksson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty
- (2008) Michael R. Lassen et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started